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Abstract
Holistic and multi-disciplinary responses should be prioritized given the depth and breadth through which 
corruption in the healthcare sector can cover. Here, taking the Peruvian context as an example, we will reflect on 
the issue of corruption in health systems, including corruption with roots within and outside the health sector, 
and ongoing efforts to combat it. Our reflection of why corruption in health systems in settings with individual 
and systemic corruption should be an issue that is taken more seriously in Peru and beyond aligns with broader 
global health goals of improving health worldwide. Addressing corruption also serves as a pragmatic approach 
to health system strengthening and weakens a barrier to achieving universal health coverage and Sustainable 
Development Goals related to health and justice. Moreover, we will argue that by pushing towards a practice 
of normalizing the conversation about corruption in health has additional benefits, including expanding the 
problematization to a wider audience and therefore engaging with communities. For young researchers and 
global health professionals with interests in improving health systems in the early career stages, corruption 
in health systems is an issue that could move to the forefront of the list of global health challenges. This is 
a challenge that is uniquely multi-disciplinary, spanning the health, economy, and legal sectors, with wider 
societal implications.
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Tracing Corruption to its Source, Towards a Horizontal 
Rather Than Vertical Enforcement of Health Systems 
Integrity
Addressing corruption at the health systems level requires 
the support of “champions,” individuals committed to 
reducing corruption and in key positions to influence, 
and the identification of the foundations of health systems 
corruption. Due to the short duration of political terms, Dr. 
Patricia Garcia, former Minister of Health of Peru, believes it’s 
“hard to try to do things in such a short time [due to political 
turnover], [so] it’s important to build roots (the beginnings 
of policy change) for whatever will come next.”1 During 
her tenure as Minister of Health and in her work today, Dr. 
Garcia has championed the cause of reducing corruption in 
the Peruvian health system. Concerns that corruption studies 
could potentially divert attention away from more important 
issues could be mitigated by political champions who could 
guide policy formulation and implementation — no matter 
how big or small — with integrity. Initially, champions are 
needed to start with, but champions alone will not suffice, and 
programs raising consciousness about institutional corruption 
would serve to improve health professionals’ ability to see 
changes and improvements. In addition, those programs can 
serve to monitor and refine institutional changes by being 
able to better document the impact of corruption on current 
health systems, and the responses provided to it. Ultimately, 
these changes affect the health and well-being of patients and 
the entire healthcare workforce.
Careful consideration of the institutional sources and 
mechanisms that drive and sustain health corruption is 
crucial. Tracing issues to the source of their corruption 
would greatly improve the sustainability of anti-corruption 
efforts. For example, such a profound topic becomes obvious 
when scrutinizing the perceived normality associated with 
absenteeism in low- and middle-income country settings.2-4 
Health workers’ low wages and irregular payments, paired 
with weak oversight by governance systems, may bolster 
health workers’ decisions to engage in dual practice and 
missing work days.
Corruption is usually seen as stemming from informal 
behaviors that ignores public rules, regulations, and laws.3 
The problem is that perception of informality shadows and 
obscure the real penetration of such practices, usually much 
more common and larger than expected. As such, collective 
¶ Both authors contributed 
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enforcement of health sector honesty could be done by 
looking to regulatory measures like ensuring that any user, 
patients and/or providers are aware of mechanisms in place to 
oversee corruption and are comfortable in using them.
Strengthening Communication to Support Corruption 
Research: Insights From Peru
In Peru, a government-wide national plan to fight 
corruption was proposed in 2008,5 and in 2012 a High-Level 
Anticorruption Commission was established.6 In 2015, the 
Ministry of Health adopted its own plan for the health sector.7 
Yet, exposing corruption can be systematically difficult and 
dangerous to one’s credibility and career and the challenge 
comes in the form of reporting and ensuring protection for 
those who are faced with the pressure to be silenced from 
higher authority. 
Following a Legislative Decree in 20178 designed to 
empower and protect those who report acts of corruption as 
well as to punish those who make such reports in bad faith, 
the Peruvian Ministry of Health launched OTRANS (Office 
of Transparency and Anticorruption).9 A key component of 
OTRANS was the opening of a new, simplified method for 
the reporting of corruption through the Internet, by phone, 
or in writing.10,11 The reporting form can be submitted 
online or physically, and can be made from specific entities 
within the Ministry of Health and its affiliated hospitals, 
as well as regional entities. The form asks for a description 
of the purported corruption, the individual involved, and 
evidence, if available. The new reporting tool dually serves 
to increase awareness of corruption and improve the ability 
to study corruption. A centralized repository for complaints 
and concrete reports from victims/observers of corruption 
will reduce officials’ ability to shift the blame of corruption to 
those with less influence.10,12 The establishment of OTRANS 
and the updated reporting system are improved resources 
to combat corruption but do not guarantee a health system 
with less corruption. Additionally, concerns should be raised 
about the lack of transparency of the investigation and follow 
up process following the submission of a complaint. Wariness 
about the integrity of OTRANS is valuable too, and scrutiny 
can help to ensure that the office is not being manipulated for 
the ends of management or others.
In addition to becoming a hub for reporting acts of 
corruption, OTRANS also plays a role in the investigation of 
corruption. Recently, a group of doctors from a large national 
public hospital was discovered to be working in private 
offices during paid working hours.13,14 They were also found 
to offer their private patients unauthorized access to hospital 
equipment for their medical exams.13,14 These practices are 
not unique to Peru, as absenteeism and diversion of public 
resources to private operations has also been reported in other 
settings.3 Other forms of corruption, such as bribes to expedite 
treatment, diversion of patients and irregular equipment and 
drug procurement, are found in multiple countries and is 
common knowledge among individuals in the health systems. 
As corruption frequently hides behind the red tape of 
bureaucracy, a simplification of the reporting process is a step 
in the right direction to improve the exposure and correct 
the internal issues of corruption. In the same vein, publicly 
exposing and discussing the types, location, and further 
investigation of the corruption complaints received by the 
OTRANS office is needed to normalize the conversation about 
corruption. In so doing, this practice of public accountability 
will ensure that the ingrained view of “corruption happens 
and does not bother” moves away from being the norm.
Corruption Outside the Health Sector Also Affects the 
Health System 
Solutions to finding common ground over the creation and 
institutionalization of new health systems protected against 
corruption should strive to protect workers and patients 
while giving them a larger voice in the process of changing 
the current system.3,7 The yield of these mechanisms in 
overturning current practices may be minimal if the root 
of the problems are wider societal crisis. One-size-fits-all 
type-of-recommendations will not necessarily solve major 
fundamental weaknesses of the health system when contexts 
for individual corrupt practices vary.
Whilst addressing corruption within healthcare delivery 
practices appears as the most immediate angle of corruption 
within health systems, there are other macro-level areas 
where corruption occurs. Corruption in this form operates at 
higher levels in the system, at state level and beyond, and as a 
result tend to have broader reach and scale.6,15,16 Corruption in 
equipment purchasing, construction, and the pharmaceutical 
industry, among others, impact the effectiveness of health 
systems and is often centered around competing interests, 
sometimes within legal frameworks. 
When private interests are at odds with the greater good 
and public interest, the public interest can be put to the side 
as a result of state capture from suppliers looking to turn a 
profit for their investors.15 Laws and policies compromised 
to benefit private economic gain is not only the result of 
corruption but fosters continued and increased corruption. 
An example that has received some attention is within the 
pharmaceutical industry. New drugs, when first introduced 
to the market, can be monopolized for increased profit by the 
drug companies that produce them. In order to maximize the 
window of time that drugs can be sold a monopoly prices, 
companies accelerate and expedite the clinical trials process 
to push the drugs to market as soon as possible.17 Among a 
number of morally grey and ethically ambiguous behaviors 
employed to achieve this goal, researchers hired by companies 
will lobby policy-makers and influence laws to their benefit, 
at the expense of data about drug safety and the rights of 
those involved in trials. The pharmaceutical industry has also 
been found to mobilize patient groups.18 Beyond lobbying, 
companies also install ministers and other key figures friendly 
to their interests, directly allowing influence over laws 
responsible for the regulation of these companies.
In addition to the concept of capturing state regulators, 
broad political corruption also directly affects health systems 
and their effectiveness. Although there is some overlap 
between the concepts of political corruption and state capture, 
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political corruption is more associated with exchanges 
between high levels of government and private industry for 
advantages, often related to investment and procurement.19 
Corruption in the construction industry illustrates this well, 
as described by Kenny: “Construction firms bribe in order 
to obtain contracts, to increase profit margins on those 
contracts and to reduce the cost of construction.”20 As a result 
of corruption in construction, not only are health standards 
compromised but also increased costs of maintenance may be 
placed on health systems as a result of poor infrastructure. 
Also, political corruption directly affects health system in the 
area of procurement. 
A critical analysis of how the private sector infiltrates 
not just the health system but also the regulatory and 
legal infrastructure around the health system needs to be 
undertaken to better understand and combat corruption. An 
extension of this is the transition of senior officials between 
the public and private sector, facilitating certain arrangements 
when in positions of influencing decision making in the public 
sector, and then transitioning to the private sector.21 These 
external influences of corruption have a broad reach beyond 
just the health sector, and has been receiving increasing 
attention in some parts of the world. Just as progress is being 
made to reduce corruption in health sectors, attention should 
be paid to these external sources of corruption as well, where 
financial incentives from the private sector plays a large role.
Advancing Towards Corruption Research
Furthermore, the mechanisms of corruption research can only 
be as good as the infrastructure protecting those who choose 
to undertake such investigations. Consequently, the nature of 
systematic efforts to reduce health system corruption could 
be learned from existing reports on potential steps to protect 
the independence and integrity of global health research.22 
Corruption research, like any other type of research, 
will likely be funded by major donors, as this corruption 
in healthcare can well be a litmus test for implementation 
science.23 Independent committees, consisting of key 
stakeholders and representatives from the community under 
study, could be established to impede commissioning bodies’ 
interference with the collection, analysis, and dissemination of 
data. Forcing commission agencies to clearly state their intent 
behind researching a health system should reduce pressure on 
researchers to produce favorable results and protect the body 
under investigation from wrongful or misunderstanding 
censure.
Guaranteeing transparency and accountability are essential 
requisites to advance towards minimizing corruption in health 
systems. The independent offices and institutions responsible 
for conducting corruption investigations could safeguard 
themselves by encouraging senior faculty in academia to 
lead discussions between funders and implementers to deny 
unjust contractual provisions and encourage the publication 
of positive and negative research findings. Outlining a process 
for releasing controversial and politically charged results by 
senior staff would set a standard for junior investigators 
to work towards corruption-free research, and ultimately 
a corruption-free working environment, as learned on 
research integrity from other fields.22 This creates two 
perspectives to consider on how to best conduct research 
for the improvement of medical service delivery in the long 
run: ensuring corruption research does not harm the current 
health systems’ ability to treat patients, but also pushing for 
greater transparency in the interest of patient safety and risk 
exposure.18
The Future: Towards a Corruption-Free Environment
The efforts in Peru may not be isolated and experiences 
around the globe aimed towards addressing corruption in 
health systems may already be in place, albeit at different 
stages. Corruption in some forms has become normalized, 
because of how it sometimes is understood as a means to 
allow an otherwise dysfunctional health system to operate. 
Often, corruption is a well-known and acknowledged part of 
a health system.24 Just because it is the norm, however, does 
not mean that it is acceptable. Corruption that has become 
a part of the system should be re-problematized and pushed 
back into the discussion of health systems challenges. 
Equally important, being upfront about corruption should 
fall to those in training and future leaders—corruption 
should be better integrated into curricula for both researchers 
and healthcare providers and awareness should be increased. 
For young researchers and global health professionals in 
the early career stages, corruption in health systems is an 
issue that could move to the forefront of the list of global 
health challenges. This is a challenge that is uniquely 
multidisciplinary, spanning the health, economy, and legal 
sectors, with wider societal implications, much in line with 
the multidisciplinarity required to advance global health.25,26 
Discussion of corruption in health systems can affect 
discourse beyond academia and the medical field to politics, 
an essential player in facing corruption.27 Transparency 
International’s definition of corruption as “the abuse of 
entrusted power for private gain”28 is a general but foundational 
point in the discussion. As a primarily underexposed issue, 
the idea of corruption tends to narrowly frame the concept 
around individual corruption. Other forms of corruption 
that fall less neatly into this definition are less acknowledged 
and undermine health systems without much notice from 
academics or the rest of the world beyond large scale scandals. 
This theme rings true in global health education as well, despite 
documented evidence that corruption in health systems costs 
lives and money.29,30 By teaching about the challenges of 
corruption in health systems early on in the careers of the next 
generation of leaders, awareness will be improved, and, more 
importantly, the discussion on corruption will be continued. 
In pursuing this goal, how do we define corruption, 
especially when introducing it as a topic to students who 
may not yet have had exposure or practice in settings where 
they could have witnessed it firsthand? Consciousness 
of corruption, risks related to engaging corruption, and 
transparency are related topics with subtleties that need to 
be well understood. How can students engage in research on 
corruption that wholly captures situations instead of focusing 
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on a single facet or misdirecting efforts to scapegoats? The 
evidence on the effectiveness of interventions to target 
different types of corruption is scant.12 It will fall on the 
shoulders of the next generation of researchers and leaders 
to sustain the conversation around corruption, build a body 
of evidence on effective interventions and develop innovative 
responses, and work towards the goal of corruption-free 
healthcare systems.
Final Remarks
A number of obstacles still stand in the way of approaching 
corruption as a health challenge. Among the many solutions 
and proposals to deal with corruption, a common thread 
of continued, sustained discourse can be identified. From 
identifying champions to better address corruption and 
establishing oversight to monitor both corruption and 
corruption research, an increase in the public and academic 
eye on corruption in health systems is key to problematizing 
the issue and making the reduction (or eradication!) of 
corruption a priority. A longer term approach to achieving 
this goal is through leveraging on opportunistic environments 
provided by the years of education and training of future 
healthcare professionals. Generally speaking, how can we 
teach and study corruption in a way that supports the goals 
of global health, and how can we learn and develop new 
ways to combat corruption? Questions still remain in the 
effort to take a stand against corruption, but it is clear that 
continued, sustained dialogue will be essential to accomplish 
this task, mainly because corruption that affect health and 
well-being occurs within and outside the health sector. 
Actions conducting towards a corruption-free environment 
need to be taken but close consideration must also be given 
to the importance and feasibility of those actions. And, in 
particular, those actions need to become the norm rather than 
the exception as we push away from a society with systemic 
corruption and work towards the goal of corruption-free 
healthcare systems.
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